Enhancing sustained-release local therapy: single versus dual chemotherapy for the treatment of neuroblastoma.
Taylor et al. Surgery 167: 969 (2020).
3D extracellular matrix microenvironment in bioengineered tissue models of primary pediatric and adult brain tumors.
Sood et al. Nat Commun 10: 4529 (2019).
Replicating and identifying large cell neuroblastoma using high-dose intra-tumoral chemotherapy and automated digital analysis.
Taylor et al. J Pediatr Surg 54: 2595 (2019).
Silk reservoirs for local delivery of cisplatin for neuroblastoma treatment: in vitro and in vivo evaluations.
Yavuz et al. J Pharm Sci 108: 2748 (2019).
Disseminated injection of vincristine-loaded silk gel improves the suppression of neuroblastoma tumor growth.
Zeki et al. Surgery 164: 909 (2018).
In vitro and in vivo evaluation of etoposide – silk wafers for neuroblastoma treatment.
Yavuz et al. J Control Release 285: 162 (2018).
Production of curcumin-loaded silk fibroin nanoparticles for cancer therapy.
Montalban et al. Nanomaterials 8: 126 (2018).
Manipulation of variables in local controlled release vincristine treatment in neuroblastoma.
Coburn et al. J Pediatr Surg 52: 2061 (2017).
Implantable chemotherapy-loaded silk protein materials for neuroblastoma treatment.
Coburn et al. Int J Cancer 140: 726 (2017).
Focal therapy of neuroblastoma using silk films to deliver kinase and chemotherapeutic agents in vivo.
Seib et al. Acta Biomater 20: 32 (2015).
Surgery combined with controlled-release doxorubicin silk films as a treatment strategy in an orthotopic neuroblastoma mouse model.
Chiu et al. Br J Cancer 111: 708 (2014).